The National Football League and the NFL Players Association announced a joint investigation into the Philadelphia Eagles’ handling of Jalen Hurts’ blood clot condition during and around the team’s Week 5 trip to London to play the Jacksonville Jaguars. The statement from the two organisations made clear the review will focus on the events, decisions and communications that surrounded the quarterback’s diagnosis and availability.
What the probe will examine
The joint inquiry is set to look at medical care, team decision-making and protocol adherence. That includes how the Eagles’ medical staff assessed and treated Hurts, what information was shared internally and with the league and union, and whether established NFL health and safety policies were followed during the team’s overseas travel. The probe will also consider timing: when tests were done, when results were known, and how those results factored into roster and travel plans.
Chronology and immediate context
The investigation centres on the period around the Eagles’ Week 5 trip to London to face the Jacksonville Jaguars. That trip drew attention because blood clots are a serious medical condition that can affect player safety and eligibility to play. The league and the union will reconstruct a timeline of events, reviewing which staff made medical calls, who authorised travel or game-day status, and how information reached league offices. The inquiry is procedural: it seeks to establish facts rather than to assign final discipline up front.
Key areas the review will assess
- Medical assessment: Whether clinical evaluations matched accepted standards and whether follow-up testing and specialist input were obtained in a timely way.
- Information flow: How and when medical findings were communicated to the player, coaching staff, front office and the league offices.
- Travel decisions: Whether the choice to include or exclude a player from an overseas roster complied with protocols that govern high-risk medical conditions.
- Roster handling: How the team categorised and reported the player’s status to the league and whether that reporting followed NFL policy.
Medical and roster implications for the team
A confirmed blood clot diagnosis has immediate consequences for player health and practice availability. Teams must balance competitive needs with medical clearance requirements and player safety. The inquiry will look at how the Eagles managed that balance. Any showing that standard procedures were not followed could trigger league discipline, changes to team protocol, or both. The investigation will also inform how the Eagles and other clubs handle similar situations in the future, especially when international travel is involved.
Possible outcomes and precedents
Past NFL investigations into medical or administrative handling have produced a range of outcomes, from procedural recommendations to fines or other sanctions where violations were found. The joint nature of this probe — conducted by the league and the players’ union together — tends to focus on establishing a shared factual record and on corrective steps rather than immediate punishment. Findings could lead to policy clarifications about overseas travel, updated medical-reporting requirements, or mandated training for club medical and front-office personnel.
Next steps and what to expect
The league and the NFLPA will gather documents, medical records and witness reports as part of their fact-finding. That process typically includes interviews with club medical staff, front-office personnel and coaches, along with review of test results and internal communications. The organisations will then decide whether further action is warranted. Until the investigation concludes, the league and the union are unlikely to release detailed interim findings; the focus in the short term is on completing a thorough review.
This probe addresses immediate concerns about safety and transparency. It also has broader implications for how clubs manage serious medical issues during travel and high-stakes scheduling, such as international games. The outcome will be closely watched by players, clubs and the wider league because it will shape expectations around medical decision-making and accountability going forward.
